Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-02
2010-06-01
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07727959
ABSTRACT:
The present invention relates to the use of substances with oxytocin activity against climacteric disorders or similar symptoms due to dysfunction in the ovaries. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against climacteric disorders.
REFERENCES:
patent: 4889844 (1989-12-01), Silvetti et al.
patent: 5457128 (1995-10-01), Yanagawa
patent: 5753266 (1998-05-01), Youssefyeh et al.
patent: 6260621 (2001-07-01), Furman et al.
patent: 6333313 (2001-12-01), Copland et al.
patent: 2004/0176284 (2004-09-01), Uvnas-Moberg et al.
patent: WO 9843661 (1998-10-01), None
patent: 00/18424 (2000-04-01), None
patent: WO 02/067974 (2002-09-01), None
John A. Copland et al., “Functional Oxytocin Receptors Discovered in Human Osteoblasts,” Endocrinology, 1999, pp. 4371-4374.
‘Oxytocin’ http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202434.html accessed Oct. 28, 2004. Revised Jun. 30, 1994.
BF Mitchel et al. Reviews of Reproduction (1998)3, 113-122.
Lundeberg Thomas
Uvnäs-Moberg Kerstin
Kosar Andrew D
Pep-Tonic Medical AB
Young & Thompson
LandOfFree
Use of substances with oxytocin activity against climacteric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of substances with oxytocin activity against climacteric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of substances with oxytocin activity against climacteric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4193032